SARS-CoV-2 vaccines in development
Krammer, Florian·2020·Nature
Cited by (1,004)
Items 1,001–1,004 of 1,004
- Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 PatientsLuzia Maria de‐Oliveira‐Pinto, Víctor Fiestas Solórzano, Maria de Lourdes Martins, Caroline Fernandes-Santos, Paula Hesselberg Damasco, Marilda Mendonça Siqueira, Helver Gonçalves Dias, Alex Pauvolid‐Corrêa, Paulo Vieira Damasco, Elzinandes Leal de Azeredo · 2022 · Viruses
- A Disproportionality Analysis for Association of Systemic Capillary Leak Syndrome with COVID-19 Vaccination Using the World Health Organization Pharmacovigilance DatabaseJin Myung Park, Dongyeop Kim, Tae‐Jin Song · 2022 · Vaccines
- Adjuvants to increase immunogenicity of SARS-CoV-2 RBD and support maternal–fetal transference of antibodies in miceGabrielle Gimenes Lima, Amanda Izeli Portilho, Elizabeth De Gaspari · 2022 · Pathogens and Disease
- Two formulations of coronavirus disease‐19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in miceErkan Özcengīz, Duygu Keser, Gülay Özcengiz, Gözde Çelik, Aykut Özkul, Fatma Nur İnçeh · 2022 · Immunity Inflammation and Disease